The side effects and hazards of DaliRax (Keweike) and how to deal with safe medication

1. Overview of Drugs

Daridorexant is an oral dual orexin receptor antagonist (DORA, dual orexin receptor antagonist), mainly used to treat primary insomnia (insomnia disorder). By selectively blocking the Orexin-1 and Orexin-2 receptors in the brain, the arousal signal is inhibited, thereby improving the difficulty in falling asleep and night awakening problems. Compared with traditional benzodiazepines, DaliRazen has the advantages of low addiction, low tolerance and less risk of cognitive impairment, making it a new clinical choice for patients with long-term insomnia.

Clinical studies have shown that DaliRasen can significantly shorten the sleep onset latency, prolong the total sleep time, and improve sleep quality and daytime wakefulness performance. It also shows good tolerability and safety in elderly patients, providing treatment options for insomnia patients of different ages.

2. Common side effects and hazards

Although Dalirasin is well tolerated, it may still cause certain side effects, some of which may have an impact on daily life. Common side effects include:

1.Daytime sleepiness and fatigue

DaliRazen improves nighttime sleep by suppressing arousal signals, but may cause drowsiness, fatigue, or decreased concentration during the day. Some patients have potential risks when they get up in the morning or when driving or operating machinery, and they need to avoid high-risk activities until they adapt to the medication.

2.Headache and dizziness

Clinical observation found that some patients will experience mild to moderate headache or dizziness, especially in the early stages of medication. This may affect work and life and needs to be alleviated by adjusting the medication time or treating symptoms.

3.Nausea and indigestion

Individual patients may experience mild nausea, stomach discomfort, or indigestion. Mild nausea, stomach discomfort, or indigestion usually resolve on their own after continuing to take the medication for a few days. Severe cases require medical treatment or auxiliary drugs to relieve symptoms.

4.Rare but serious adverse reactions

Abnormal nighttime behaviors: such as sleepwalking, talking in sleep, or eating at night, especially when combined with other central depressant drugs, the risk increases.

Falls or fractures: Particularly in older patients, nighttime sleepiness may increase the risk of falls.

Allergic reaction: A very small number of patients may develop rash, itching or respiratory allergic reaction and need to stop taking the drug immediately and seek medical advice.

3. Methods for safe medication use

In order to reduce the risk of side effects and ensure medication safety, the use of DaliRasen should follow the following guidelines:

1.Dosage and taking time

The recommended dose is usually 10mg or 25mg orally, once every night before going to bed, swallow the whole tablet.

After taking the medicine, you should ensure at least7 hours of sleep to avoid daytime sleepiness or decreased concentration due to getting up too early.

2.Initial adaptation and monitoring

Dizziness, fatigue or mild nausea may occur in the early stages of medication. You should observe your body's reaction at home and avoid high-risk activities (such as driving and operating machinery).

Elderly patients or those with impaired liver and kidney function should evaluate the starting dose under the guidance of a physician and closely monitor drug tolerance.

3.Adverse reaction management

Daytime sleepiness or fatigue: This can be managed by adjusting sleep times, limiting daytime naps, or spreading out high-risk activities.

Headache and dizziness: For mild symptoms, you can take oral symptomatic medications, keep hydrated and rest. In severe cases, consult your doctor to adjust the dosage.

Indigestion: May be taken with food or combined with a mild digestive medication to relieve symptoms.

Abnormal behavior at night: If sleepwalking, talking in sleep, etc. occur, you should stop taking the medicine immediately and seek medical treatment to avoid accidental injury.

4.Drug interactions

Daliramin is metabolized by CYP3A4, and combined use with strong CYP3A4 inhibitors or inducers may affect blood concentration. When using other centrally depressant drugs (such as benzodiazepines or sedative antidepressants), the drugs should be used together with caution and the dosage should be adjusted under the guidance of a doctor.

4. Patient education and long-term management

1. Medication compliance: Patients need to take medication at a fixed time every day before going to bed to ensure stable drug efficacy. Do not stop taking the medicine or take it again at will.

2. Lifestyle adjustments: Maintaining a regular schedule, avoiding caffeine and stimulating drinks, and exercising moderately can help improve sleep quality and reduce side effects.

3.Follow-up and monitoring: It is recommended to follow-up once a week in the early stage of medication to evaluate the sleep improvement effect and side effects. During long-term treatment, liver and kidney function, blood pressure and quality of life indicators can be reviewed monthly.

4.Psychological support: Patients with insomnia may be accompanied by symptoms of anxiety or depression. If necessary, psychological intervention or cognitive behavioral therapy can be combined to improve the treatment effect.

Daridorexant (Daridorexant), as a dual Orexin receptor antagonist, provides patients with primary insomnia with a highly effective, low-addictive and well-tolerated treatment option. Common side effects include daytime drowsiness, headache, nausea, etc. Some elderly patients or those taking combined medications are at risk of falling and abnormal behavior at night. Through reasonable dosage, fixed medication time, initial adaptation and regular monitoring, the harm of side effects can be effectively reduced. Patient education, lifestyle adjustment and psychological support are also important links in ensuring safe medication use. The combination of scientific medication and follow-up management can achieve the goals of improving sleep and quality of life while ensuring medication safety.

Reference materials:https://www.drugs.com/

xa0